-+ 0.00%
-+ 0.00%
-+ 0.00%

SECRETOME THERAPEUTICS ANNOUNCES INITIATION OF THRIVE-2 PHASE 2 CLINICAL STUDY EVALUATING STM-01 IN DUCHENNE MUSCULAR DYSTROPHY

Reuters·09/29/2026 12:00:37

Please log in to view news